Late-stage global trials for the protein-based Sanofi vaccine candidate began in May. AFP
Late-stage global trials for the protein-based Sanofi vaccine candidate began in May. AFP
Sanofi and GSK start Covid vaccine 'rolling review'
French and British drugmakers hope to gain approval for Vidprevtyn by end of year
